WallStreetZenWallStreetZen

NASDAQ: ADVM
Adverum Biotechnologies Inc Stock Ownership - Who owns Adverum Biotechnologies?

Insider buying vs selling

Have Adverum Biotechnologies Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Braden Michael Leonard10% Owner2024-07-3085,800$7.15
$613.47kBuy
Braden Michael Leonard10% Owner2024-07-1880,718$9.12
$735.74kBuy
Braden Michael Leonard10% Owner2024-07-17135,546$7.75
$1.05MBuy
Jr Mark L. LupherDirector2024-02-07130,000$1.35
$175.50kBuy
James Paul ScopaDirector2024-02-07100,000$1.35
$135.00kBuy

1 of 1

ADVM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADVM insiders and whales buy or sell their stock.

ADVM Shareholders

What type of owners hold Adverum Biotechnologies Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Versant Ventures Iv LLC33.67%7,003,892$48.96MInsider
Zygtech LLC11.72%2,438,176$17.04MInsider
Braden Michael Leonard11.41%2,372,864$16.59MInsider
Venrock Associates Vi LP11.37%2,365,471$16.53MInsider
Venrock Healthcare Capital Partners Ii LP11.37%2,365,471$16.53MInsider
James E. Flynn10.57%2,197,679$15.36MInsider
Tcg Crossover Management LLC9.66%2,008,340$14.04MInstitution
Bml Capital Management LLC9.45%1,966,000$13.74MInstitution
Regeneron Pharmaceuticals Inc8.70%1,809,098$12.65MInsider
Franklin Resources Inc8.46%1,760,052$12.30MInstitution

1 of 3

ADVM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADVM39.88%60.12%Net BuyingNet Buying
ACHV54.09%27.74%Net BuyingNet Buying
ABOS72.54%16.58%Net Selling
MOLN2.59%0.00%
MCRB45.55%30.06%Net SellingNet Selling

Adverum Biotechnologies Stock Ownership FAQ

Who owns Adverum Biotechnologies?

Adverum Biotechnologies (NASDAQ: ADVM) is owned by 85.91% institutional shareholders, 129.52% Adverum Biotechnologies insiders, and 0.00% retail investors. Versant Ventures Iv LLC is the largest individual Adverum Biotechnologies shareholder, owning 7.00M shares representing 33.67% of the company. Versant Ventures Iv LLC's Adverum Biotechnologies shares are currently valued at $52.53M.

If you're new to stock investing, here's how to buy Adverum Biotechnologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.